Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study.

ABSTRACT:

SUBMITTER: Baden LR 

PROVIDER: S-EPMC7529856 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature